MLL represented the patent proprietor AstraZeneca in the proceedings. The patent proprietor AstraZeneca has been involved in patent infringement proceedings against Sandoz, concerning AstraZeneca’s fulvestrant formulation…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
